Pharmaceuticals firm Novartis is moving its Dutch offices from Arnhem to Amsterdam next year, in anticipation of the arrival of the European Medicines Agency in the Dutch capital.

Novartis Nederland, which is essentially a sales operation, employs almost 400 people in Arnhem but had been looking for a new location and updated offices.

The choice for Amsterdam was made because of the ‘many important partners, including universities, research institutes and the EMA,’ general director Heinrich Moisa is quoted as saying in the Financieele Dagblad.

The EMA is moving to the Netherlands as a consequence of Brexit.